In prostate cancer, HOXB13, which is highly expressed in adulthood in the normal prostate [43], functions as a coregulator of AR, together with FOXA1, to modulate the epigenetic status required for prostate tumorigenesis [15,16]. Here, AR is linked to prostate cancer.